Brief: Emerald Bioscience Reports Publication In Peer-Reviewed Journal
Dec 16 (Reuters) - Emerald Bioscience Inc EMBI.PK :
* EMERALD BIOSCIENCE REPORTS THAT SUPERIOR REDUCTION OF
INTRAOCULAR PRESSURE OF ITS UNIQUE NANOEMULSION FORMULATION OF
THCVHS IS PUBLISHED IN PEER-REVIEWED JOURNAL
Source text for Eikon: ID:nGNX6VX0md
Further company coverage: EMBI.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Skye Bioscience
See all newsBrief: Skye Announces Cohort Review Committee Approved Opening Of Cohort 2 Based On Favorable Safety Data From First Four Participants Treated In Cohort 1
U.S. RESEARCH ROUNDUP-Accuray, Aevex, Zoetis
U.S. STOCKS ON THE MOVE-Tesla, Blue Owl, Ford
U.S. STOCKS ON THE MOVE-Energy firms, Estee Lauder, HMH Holding
Skye Bioscience rises as it begins testing higher doses of obesity drug